ada tirzepatide 2021: Demonstrates Potential in Type 2 Diabetes with SURPASS Trials Tirzepatide noninferior, superior to semaglutide

Weight Loss Results to Expect With consistent weekly injections and healthy lifestyle choices, many clients experience: Steady weight loss of 13 lbs per week Reduced belly fat and body circumference Improved energy, fewer cravings, and better portion control Most people start noticing changes in weeks 24 , with full results continuing over several months

This is where microdosing provides a different way to approach the problem

There are documented case reports of extreme appetite suppression and psychiatric complications requiring GLP-1 discontinuation in people with restrictive eating patterns ( Leziak et al., J Psychiatric Research, 2026 )

Both medications can cause gastrointestinal discomfort, but these side effects often lessen over time

It also helps reduce cholesterol and triglyceride levels, lowering the risk of cardiovascular disease and possesses anti-inflammatory properties that contribute to overall health benefits